Fig. 1.
Clinical presentation of the patient after 2 cycles of pembrolizumab. (A, B) Numerous dark red plaques covered by scales and crusts on the face. Erosions on (C) the lips and (D) the hard palate.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.